Physician profile
Brittany Mae Jaisankar
NPI 1134862774
$234.23
in general payments reported to CMS, 2019-2025
9 companies · $234 in 2025
The $234 reported for 2025 was more than what 83% of Pediatrics, Critical Care providers received nationally (typical 2025 total: $80.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47.02 | 2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Collegium Pharmaceutical, INC. | $36.01 | 2025 | Jornay Pm |
| Azurity Pharmaceuticals, INC. | $27.60 | 2025 | Alvesco |
| Organon LLC | $24.08 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $21.37 | 2025 | Neffy |
| Corium, LLC | $20.97 | 2025 | Azstarys |
| Seqirus USA INC | $20.20 | 2025 | Flucelvax |
| Glaxosmithkline, LLC. | $19.78 | 2025 | Bexsero |
| Tris Pharma INC | $17.20 | 2025 | Onyda Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Jaisankar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.